A Phase IIb, 4-arm, open-label, randomized, multi-center study to assess the safety and efficacy of radiation/chemoradiation therapy in combination with the novel anti-EGFR monoclonal antibody h-R3 in patients with advanced (stage III or IVa) inoperable h
| Title: | A Phase IIb, 4-arm, open-label, randomized, multi-center study to assess the safety and efficacy of radiation/chemoradiation therapy in combination with the novel anti-EGFR monoclonal antibody h-R3 in patients with advanced (stage III or IVa) inoperable h |
|---|---|
| Authors: | Dr.Lokesh Viswanth M.D, Kidwai Memorial Institute of Oncology, Bangalore 560029 |
| Presenter: | Lokesh Viswanath - Contact |
| Category: | Head/Neck |
| Language: | English |
| Download link: | View this poster |
| Date of Validation: | 2009-06-11 |